TRANSCELLULAR PERMEABILITY OF CHLORPROMAZINE DEMONSTRATING THE ROLES OF PROTEIN-BINDING AND MEMBRANE PARTITIONING

被引:43
作者
SAWADA, GA
HO, NFH
WILLIAMS, LR
BARSUHN, CL
RAUB, TJ
机构
[1] UPJOHN CO,UPJOHN LABS,CENT NERVOUS SYST RES,KALAMAZOO,MI 49007
[2] UPJOHN CO,UPJOHN LABS,DRUG DELIVERY SYST RES,KALAMAZOO,MI 49001
关键词
BIOPHYSICAL MODEL; CELL CULTURE MODEL; CHLORPROMAZINE; PERMEABILITY;
D O I
10.1023/A:1018916027099
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Transcellular permeability of the neuroleptic-anesthetic chlorpromazine (CPZ) was examined using a cell type (MDCK) that forms a confluent monolayer of polarized cells resulting in distinct apical (AP) and basolateral (BL) membrane domains separated by tight junctions. Because CPZ is membrane interactive, transmonolayer flux was analyzed as two kinetic events: cell uptake from the AP donor solution and efflux into the BL side receiver. Using the rate of cell uptake in the presence of different concentrations of BSA, an intrinsic cell partition coefficient of 3700 +/- 130 and an operational dissociation binding constant of 0.4 +/- 0.05 mM were calculated. In contrast to uptake, efflux of CPZ from either the AP or the BL side of the cell monolayer was similar to 10(4)-fold slower and was dependent upon the avidity of CPZ for the protein acceptor in the receiver solution. These results emphasized the importance of simultaneously measuring disappearance of a lipophilic molecule from the donor solution and its appearance in the receiver and demonstrated how interactions with proteins on either side of the cellular barrier influence permeability. Appearance kinetics showed that the composition of the receiving environment is critical to model a particular in vivo situation and implied that the intrinsic permeability of membrane-interactive molecules in vitro does not necessarily predict penetration beyond the initial cellular barrier in vivo.
引用
收藏
页码:665 / 673
页数:9
相关论文
共 30 条
[11]  
GABAY S, 1974, PHENOTHIAZINES STRUC, P175
[12]   MECHANISMS OF CORNEAL DRUG PENETRATION .2. ULTRASTRUCTURAL ANALYSIS OF POTENTIAL PATHWAYS FOR DRUG MOVEMENT [J].
GRASS, GM ;
ROBINSON, JR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) :15-23
[13]   HYDROPHOBIC AND IONIC INTERACTIONS OF PHENOTHIAZINE DERIVATIVES WITH BOVINE SERUM-ALBUMIN [J].
KRIEGLSTEIN, J ;
STAAB, J ;
MEILER, W .
BIOCHEMICAL PHARMACOLOGY, 1972, 21 (07) :985-+
[14]  
LUNDE P, 1984, DRUG PROTEIN BINDING, P201
[15]   PARTITION OF CHLORPROMAZINE INTO LIPID BILAYER-MEMBRANES - THE EFFECT OF MEMBRANE-STRUCTURE AND COMPOSITION [J].
LUXNAT, M ;
GALLA, HJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 856 (02) :274-282
[16]  
MASON RP, 1989, MOL PHARMACOL, V36, P634
[17]   CHARACTERIZATION OF A COMMON BINDING-SITE FOR BASIC DRUGS ON HUMAN ALPHA-1-ACID GLYCOPROTEIN (OROSOMUCOID) [J].
MULLER, WE ;
STILLBAUER, AE .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1983, 322 (02) :170-173
[18]  
Muller WE, 1986, PROTEIN BINDING DRUG, P29
[19]  
OLDENDORF WH, 1981, RES METHODS NEUROCHE, V5, P91
[20]   TRANSPORT OF PROTEIN-BOUND HORMONES INTO TISSUES INVIVO [J].
PARDRIDGE, WM .
ENDOCRINE REVIEWS, 1981, 2 (01) :103-123